Statistical validation of synthetic data for lung cancer patients generated by using generative adversarial networks
Visualitza/Obre
10.3390/electronics11203277
Inclou dades d'ús des de 2022
Cita com:
hdl:2117/382001
Tipus de documentArticle
Data publicació2022-10-01
Condicions d'accésAccés obert
Llevat que s'hi indiqui el contrari, els
continguts d'aquesta obra estan subjectes a la llicència de Creative Commons
:
Reconeixement 4.0 Internacional
Abstract
The development of healthcare patient digital twins in combination with machine learning technologies helps doctors in therapeutic prescription and in minimally invasive intervention procedures. The confidentiality of medical records or limited data availability in many health domains are drawbacks that can be overcome with the generation of synthetic data conformed to real data. The use of generative adversarial networks (GAN) for the generation of synthetic data of lung cancer patients has been previously introduced as a tool to solve this problem in the form of anonymized synthetic patients. However, generated synthetic data are mainly validated from the machine learning domain (loss functions) or expert domain (oncologists). In this paper, we propose statistical decision making as a validation tool: Is the model good enough to be used? Does the model pass rigorous hypothesis testing criteria? We show for the case at hand how loss functions and hypothesis validation are not always well aligned.
CitacióGonzález Abril, L. [et al.]. Statistical validation of synthetic data for lung cancer patients generated by using generative adversarial networks. "Electronics (Switzerland)", 1 Octubre 2022, vol. 11, núm. 20, article 3277, p. 1-15.
ISSN2079-9292
Versió de l'editorhttps://www.mdpi.com/2079-9292/11/20/3277
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
electronics-11-03277.pdf | 867,9Kb | Visualitza/Obre |